Who Owns Rein Therapeutics Stock?
NASDAQ: RNTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 1:29 PM ET
Ownership breakdown
- Held by institutions
- 52.37%
- Held by insiders
- 5.02%
- Institutional holders
- 66
- Institutions 52.4%
- Insiders 5.0%
- Public and other 42.6%
Who owns Rein Therapeutics stock?
Institutional investors own about 52.4% of Rein Therapeutics's shares, spread across 66 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 5.02% of RNTX.
The largest institutional holders are Voss Capital, LP (6.10%), Cable Car Capital, LP (6.02%) and Adar1 Capital Management, LLC (5.22%). Together, the top 10 institutions control 37.4% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their RNTX positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of RNTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Voss Capital, LP | 5.26M | 6.10% | +19.9% |
| Cable Car Capital, LP | 5.20M | 6.02% | +1136.9% |
| Adar1 Capital Management, LLC | 4.50M | 5.22% | +100.0% |
| Vanguard Capital Management LLC | 3.38M | 3.92% | +238.3% |
| Bios Capital Management, LP | 2.98M | 3.46% | +50.4% |
| Ikarian Capital, LLC | 2.95M | 3.42% | +100.0% |
| Great Point Partners LLC | 2.58M | 2.98% | +100.0% |
| Citadel Advisors Llc | 2.44M | 2.83% | +100.0% |
| Velan Capital Investment Management LP | 1.70M | 1.97% | +100.0% |
| Senvest Management LLC | 1.23M | 1.43% | +433.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of RNTX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.52M | 2.92% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 785.54K | 0.91% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 369.23K | 0.43% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 105.68K | 0.12% |
| iShares Trust-iShares Micro-Cap ETF | 86.49K | 0.10% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 82.70K | 0.10% |
| Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | 76.00K | 0.09% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 46.34K | 0.05% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 43.37K | 0.05% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 26.10K | 0.03% |
Frequently asked questions
Who is the largest shareholder of Rein Therapeutics?
Voss Capital, LP is the largest institutional shareholder of RNTX, owning 6.10% of shares outstanding (5.26M shares) as of its latest 13F filing.
What percentage of Rein Therapeutics is owned by institutions?
Institutions own about 52.4% of RNTX shares and 55.1% of the public float.
How much of Rein Therapeutics do insiders own?
Insiders, such as officers and directors, own about 5.02% of RNTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.